Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib in Relapsed/Refractory Peripheral T/NK Cell Lymphoma
NCT04705090Phase 2Unknown
- Sponsor
- Yingli Pharma
- Start
- Apr 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of linperlisib in peripheral T-cell lymphoma (PTCL), natural killer cell lymphoma, sponsored by Yingli Pharma. Status: unknown.
02
Drugs
linperlisib
03
Conditions
peripheral T-cell lymphoma (PTCL)natural killer cell lymphoma
Beyond the preview
Go deeper on NCT04705090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705090.